Related Experiment Video
Updated: Jul 28, 2026

A Convenient Method for Extraction and Analysis with High-Pressure Liquid Chromatography of Catecholamine Neurotransmitters and Their Metabolites
Published on: March 1, 2018
Impurities in Illicit Drug Preparations: Amphetamine and Methamphetamine
1National Forensic Science Laboratory of the Ministry of Justice, Volmerlaan, Rijswijk, The Netherlands.
This review details impurities in illicit amphetamine and methamphetamine, focusing on chromatographic and mass spectral properties. Identifying these "route-specific" impurities aids in distinguishing synthesis methods used in clandestine drug production.
Area of Science:
- Forensic Chemistry
- Analytical Chemistry
Background:
- Illicit amphetamine and methamphetamine preparations contain numerous impurities.
- These impurities often stem from incomplete purification during clandestine synthesis.
Purpose of the Study:
- To review the chromatographic and mass spectral properties of identified impurities in illicit amphetamine and methamphetamine.
- To discuss synthesis routes and methods for isolating and preconcentrating impurities.
- To highlight the significance of impurity profiling for differentiating drug origins.
Main Methods:
- Review of existing literature on amphetamine and methamphetamine synthesis and impurity analysis.
- Analysis of chromatographic and mass spectral data of known impurities.
- Discussion of isolation and preconcentration techniques for trace contaminants.
Main Results:
- Detailed survey of known impurities in illicit amphetamine and methamphetamine.
- Characterization of impurities using mass spectral and chromatographic properties.
- Emphasis on the Leuckart route as a common synthetic method for amphetamine.
Conclusions:
- Impurity profiling is crucial for forensic analysis of illicit drugs.
- "Route-specific" impurities can indicate the synthetic pathway used.
- Understanding impurity profiles aids in combating illicit drug manufacturing.
Related Concept Videos
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
CNS Stimulants: Psychedelic Agents
Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...

